Permira eyes Arysta LifeScience IPO


Japanese flag poleUK private equity firm Permira is reportedly considering floating farming chemicals company Arysta LifeScience in New York.

Permira has met banks about a potential IPO of the Japanese company, which could be valued at around $4bn including debt, said the FT, citing people with knowledge of the situation.

The negotiations are at an early stage and the firm could consider selling the firm to a trade buyer, said one of the sources. Arysta has been talking to bankers about whether to move its domicile from Japan to the US or another jurisdiction with lower corporate tax rates, while also considering reconciling its reporting metrics to meet US accounting standards, said the report.

Permira bought Arysta for €1.95bn in 2008 in its first deal in Japan.

Last month Permira finalised a deal to acquire the regional businesses of Tilney in Birmingham, Edinburgh, Glasgow and Liverpool from Deutsche Bank.

Copyright © 2014 AltAssets